Original language | English |
---|---|
Number of pages | 1 |
Journal | Journal of Pharmacology and Experimental Therapeutics |
Volume | 333 |
Issue number | 3 |
State | Published - Jun 1 2010 |
Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis (The Journal of Pharmacology and Experimental Therapeutics (2010) 332, (1022-1031))
S. Zaitzev, D. Spitzer, J. C. Murciano, B. S. Ding, S. Tliba, M. A. Kowalska, K. Bdeir, A. Kuo, V. Stepanova, J. P. Atkinson, M. Poncz, D. B. Cines, V. R. Muzykantov
- Institute of Clinical and Translational Sciences
- Siteman Cancer Center
- Division of Rheumatology
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Section of Hepatobiliary-Pancreatic & Gastrointestinal Surgery
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Rheumatic Diseases Research Resource-Based Center
- DBBS - Human and Statistical Genetics
- DBBS - Immunology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- Hope Center for Neurological Disorders
Research output: Contribution to journal › Comment/debate